Fresenius
€43.64Change from previous close: −0.38%Absolute change: −€0.16
At a glance
- Revenue growth
- +4.19%
- 2025 vs 2024
- Net income growth
- +168.37%
- 2025 vs 2024
- Net margin
- 5.5%
- 2024: 2.1%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 2,574 | 2,447 | 4,456 | 4,198 | — |
| Depreciation and amortization | 1,120 | 1,239 | 1,400 | 1,157 | — |
| Capital expenditure | -1,497 | -1,060 | -1,286 | -1,193 | — |
| Investing cash flow | -815 | -510 | -3,187 | -2,607 | — |
| Financing cash flow | -2,423 | -2,183 | -1,377 | -1,604 | — |
| Dividends paid | -684 | 0.0 | -551 | -403 | -1,068 |
| Share repurchases | — | — | — | — | 0.0 |
| Debt issued | 2,111 | 302 | 2,520 | 2,933 | — |
| Debt repaid | -3,671 | -2,298 | -1,634 | -2,394 | — |
| Effect of exchange rates | -33.0 | -2.0 | -43.0 | -2.0 | — |
| Net change in cash | -664 | -246 | -108 | -13.0 | — |
| Free cash flow | 1,077 | 1,387 | 3,170 | 3,005 | — |
